Entheon Biomedical Corp. (ENBI.CN)
CAD 0.13
(8.33%)
CAD 0.13
(8.33%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 401.07 Thousand CAD | -47.86% |
| 2022 | 769.22 Thousand CAD | -92.29% |
| 2021 | 9.97 Million CAD | 123.06% |
| 2020 | 4.47 Million CAD | 159.82% |
| 2019 | 1.72 Million CAD | -6.58% |
| 2018 | 1.84 Million CAD | 229.64% |
| 2017 | 559.04 Thousand CAD | 845.73% |
| 2016 | 59.11 Thousand CAD | 30.31% |
| 2015 | 45.36 Thousand CAD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 335.38 Thousand CAD | 14.89% |
| 2024 Q3 | 249.31 Thousand CAD | -25.66% |
| 2024 Q1 | 291.9 Thousand CAD | -27.22% |
| 2023 FY | 401.07 Thousand CAD | -47.86% |
| 2023 Q2 | 574.32 Thousand CAD | -14.44% |
| 2023 Q1 | 671.21 Thousand CAD | -12.74% |
| 2023 Q4 | 401.07 Thousand CAD | -6.91% |
| 2023 Q3 | 430.86 Thousand CAD | -24.98% |
| 2022 Q2 | 7.4 Million CAD | -11.03% |
| 2022 Q3 | 6.68 Million CAD | -9.65% |
| 2022 FY | 769.22 Thousand CAD | -92.29% |
| 2022 Q1 | 8.32 Million CAD | -16.6% |
| 2022 Q4 | 769.22 Thousand CAD | -88.5% |
| 2021 Q2 | 10.08 Million CAD | -16.15% |
| 2021 FY | 9.97 Million CAD | 123.06% |
| 2021 Q1 | 12.03 Million CAD | 169.03% |
| 2021 Q4 | 9.97 Million CAD | -4.09% |
| 2021 Q3 | 10.4 Million CAD | 3.11% |
| 2020 FY | 4.47 Million CAD | 159.82% |
| 2020 Q4 | 4.47 Million CAD | 251.05% |
| 2020 Q2 | 1.67 Million CAD | -2.68% |
| 2020 Q1 | 1.72 Million CAD | -0.68% |
| 2020 Q3 | 1.27 Million CAD | -23.95% |
| 2019 Q2 | 1.76 Million CAD | -4.26% |
| 2019 FY | 1.72 Million CAD | -6.58% |
| 2019 Q4 | 1.73 Million CAD | -1.15% |
| 2019 Q3 | 1.75 Million CAD | -0.61% |
| 2019 Q1 | 1.84 Million CAD | 29.96% |
| 2018 Q2 | 1.67 Million CAD | 199.57% |
| 2018 Q3 | 1.44 Million CAD | -13.95% |
| 2018 Q4 | 1.41 Million CAD | -1.6% |
| 2018 Q1 | 559.04 Thousand CAD | 0.0% |
| 2018 FY | 1.84 Million CAD | 229.64% |
| 2017 FY | 559.04 Thousand CAD | 845.73% |
| 2016 FY | 59.11 Thousand CAD | 30.31% |
| 2015 FY | 45.36 Thousand CAD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | 4.19 Million CAD | 90.436% |
| Asep Medical Holdings Inc | 25.61 Million CAD | 98.434% |
| BetterLife Pharma Inc. | 324.74 Thousand CAD | -23.505% |
| BioVaxys Technology Corp. | 113.47 Thousand CAD | -253.44% |
| ChitogenX Inc. | 534 Thousand CAD | 24.892% |
| Rapid Dose Therapeutics Corp. | 1.88 Million CAD | 78.725% |
| Defence Therapeutics Inc. | 477.74 Thousand CAD | 16.048% |
| Gemina Laboratories Ltd. | 1.45 Million CAD | 72.459% |
| Glow Lifetech Corp. | 1.91 Million CAD | 79.034% |
| Lexston Life Sciences Corp. | 750.94 Thousand CAD | 46.591% |
| Pharmala Biotech Holdings Inc. | 2.41 Million CAD | 83.375% |
| Doseology Sciences Inc. | 1.1 Million CAD | 63.612% |
| MYND Life Sciences Inc. | 797.54 Thousand CAD | 49.711% |
| Nova Mentis Life Science Corp. | 31.05 Thousand CAD | -1191.339% |
| PharmaTher Holdings Ltd. | 2.58 Million CAD | 84.513% |
| PreveCeutical Medical Inc. | 181.51 Thousand CAD | -120.967% |
| Telescope Innovations Corp. | 3.02 Million CAD | 86.735% |